Galectin Therapeutics Inc (GALT)

2.70 -0.03  -1.10% NASDAQ Aug 10, 08:01 USD
View Full Chart
Price Chart
View All Events


Date Type Description
08/07/2020 Earnings Galectin Therapeutics Inc Second Quarter Earnings Results in 2020
05/11/2020 Earnings Galectin Therapeutics Inc First Quarter Earnings Results for 2020
03/16/2020 Earnings Galectin Therapeutics Inc Fourth Quarter Earnings Results for 2019
03/16/2020 Misc Galectin Therapeutics Inc Annual Report for 2019
12/04/2019 Misc Galectin Therapeutics Inc Annual General Meeting for 2018
11/12/2019 Earnings Galectin Therapeutics Inc Third Quarter Earnings Results for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: Georgia
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: Aug. 07, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.